{
  "dashboard": {
    "title": "Medical AI Impact Dashboard 2025",
    "overviewPanel": {
      "keyPerformanceIndicators": [
        {
          "name": "Diagnostic Accuracy (AI vs Human)",
          "value": "96.6% AI vs 85% Human",
          "trend": "↑50% fewer radiologist errors",
          "dataSource": "LYNA Algorithm, JAMA Radiology 2024"
        },
        {
          "name": "Drug Discovery Timeline",
          "value": "2–3 years (AI) vs 10–14 years (Traditional)",
          "trend": "꾼70% faster",
          "dataSource": "Insilico Medicine, FDA Draft Guidance 2025"
        },
        {
          "name": "Global Health Access Expansion",
          "value": "150M+ screening encounters",
          "trend": "↑20% TB readmission reduction",
          "dataSource": "WHO 2025 TB Plan, ToolQ Partnerships"
        },
        {
          "name": "Bias Sensitivity Gap",
          "value": "15% lower in minority populations",
          "trend": "⚠️ Regulatory framework gap",
          "dataSource": "NEJM 2023 Cardiovascular Study"
        }
      ],
      "summary": "Visualizing AI's transformative impact across diagnostics, treatment, and global health while addressing ethical challenges."
    },
    "visualizations": [
      {
        "type": "RadarChart",
        "description": "Comparatively display AI vs human diagnostic accuracy across 50+ conditions (lung nodules, breast calcifications, ECG)",
        "parameters": {
          "xAxis": "Condition Type",
          "yAxis": "Accuracy (%)",
          "filters": ["Year", "Region", "Pathology Type"]
        },
        "dataSources": ["LYNA Algorithm Validation Data", "FDA Clearance 2022"]
      },
      {
        "type": "Heatmap",
        "description": "Global health AI adoption intensity by region for TB screening, ECG monitoring, and surgical robotics",
        "parameters": {
          "geo": "Sub-Saharan Africa, North America, Southeast Asia",
          "intensityMetric": " Access Rate (%)"
        },
        "filters": ["Use Case", "Year"]
      },
      {
        "type": "BarGraph",
        "description": "Algorithmic bias disparity in AI cardiovascular models by race (white vs Black patients)",
        "parameters": {
          "xAxis": "Ethnic Group",
          "yAxis": "Model Sensitivity (%)"
        },
        "dataSources": ["NEJM 2023 Bias Study"]
      },
      {
        "type": "FunnelChart",
        "description": "Drug discovery pipeline efficiency from idea to Phase III (AI vs traditional timelines)",
        "parameters": {
          "stages": ["Molecule Design", "Preclinical", "Phase I", "Phase III"],
          "metric": "Time (Years)"
        },
        "filters": ["Disease Focus"]
      },
      {
        "type": "ScatterPlot",
        "description": "Surgical robotics ROI: Procedure precision vs cost savings across 10+ procedure types",
        "parameters": {
          "xAxis": "Procedure Time (Minutes)",
          "yAxis": "Cost Per Case ($)",
          "size": "Adoption Rate (%)"
        },
        "dataSources": ["Medtronic Hugo RAS Data", "Surgical Endoscopy 2024"]
      },
      {
        "type": "NetworkMap",
        "description": "Knowledge network showing relationships between AI domains (Diagnostics → Synthetic Data → Regulation)",
        "parameters": {
          "nodes": "AI, Synthetic Data, Regulation, Global Access, Bias",
          "edges": "Impact Correlations"
        },
        "filters": ["Actor Type", "Year"]
      },
      {
        "type": "MatrixView",
        "description": "Synthetic data validation: Project Harmonycr projections vs real-world diabetes trial outcomes",
        "parameters": {
          "xAxis": "Predicted Trajectory",
          "yAxis": "Actual Clinical Results",
          "color": "Discrepancy Index"
        },
        "dataSources": ["IBM Project Harmonycr", "NEJM Catalyst 2024"]
      }
    ],
    "filters": [
      "Year (2020–2025)",
      "Region (Global, Sub-Saharan Africa, North America)",
      "Use Case (Diagnostics, Drug Discovery, Surgery, etc.)",
      "Ethnicity (White, Black, East Asian, South Asian)",
      "Disease Focus (Cancer, Diabetes, TB, Cardiology)"
    ],
    "dataSchema": {
      "variables": {
        "PatientData": ["Demographics", "Comorbidities", "EHR History", "Genomic Data"],
        "AIPerformance": ["Accuracy (%)", "AUC", "Error Rates", "False Positives (%)"],
        "BiasMetrics": ["Ethnic Sensitivity Gaps", "Repeatability Scores", "Overfitting Risk"],
        "CostTimeEfficiency": ["Time-to-Market (Years)", "$ Per Case", "Labor Efficiency Improvements (%)"],
        "RegulatoryCompliance": ["FDA Approval Pathways", "Validation Milestones", "WHO Code Compliance"]
      },
      "relationships": [
        {
          "source": "AI/Diagnostics",
          "target": "Regulatory Frameworks",
          "type": "Mapped to",
          "evidence": "Link to FDA Pre-Cert 2.0 Requirements"
        },
        {
          "source": "Drug Discovery",
          "target": "Synthetic Data",
          "type": "Depends on",
          "evidence": "Insilico Validation via Project Harmonycr"
        },
        {
          "source": "Bias",
          "target": "Global Access",
          "type": "Impacts",
          "evidence": "WHO Grant Vetting Standards"
        }
      ]
    },
    "layout": "Grid (2x2 quadrant with dynamic sidebar)",
    "exportOptions": {
      "staticImage": "PNG/SVG",
      "dataDownload": "CSV/JSON",
      "interactiveReport": "PDF with live filters"
    }
  }
}